Familial adenomatous polyposis (FAP), which has a very high tendency of progression to colorectal cancer, is mainly caused by mutations of the adenomatous polyposis coli (APC) gene. This study systematically screened the APC mutations and observed the correlation of APC mutations with clinical manifestations of FAP.
Background
Familial adenomatous polyposis (FAP), mainly histologically characterized by the appearance of numerous (tens to thousands of) adenomas in the colon and rectum, with an estimated prevalence of 1/11 300-37 600, is a high risk (up to 100% risk without timely intervention) for progression to fatal colorectal cancer before the age of 40 years [1, 2] . Effective conservative therapeutic methods are lacking, and the total prophylactic proctocolectomy is essential for prevention of FAP [2] .
As an autosomal dominant inherited disease, FAP is mainly caused by mutations of the adenomatous polyposis coli (APC) gene (OMIM #175100) [1] . APC is large in size and is located on chromosome 5q21, encoding a 2843-amino acid APC protein [3] . APC contains 21 exons with a length of 8535 bp and exon 15 is the largest, covering over 75% of the coding sequence of APC [4] . APC is a tumor-suppressor gene and encodes a protein with multi-domains and complex functions, participating in regulation of the Wnt-signaling pathway, intercellular adhesion, cell cycle, and apoptosis [4] . APC protein regulates b-catenin, a key component of the Wnt/b-catenin signaling pathway, which plays an important role in colorectal cancer development [5] . APC mutation-induced inactivation of APC protein stimulates the Wnt/b-catenin pathway by increasing the nuclear accumulation of b-catenin [6] , which induces the expression of various proto-oncogenes such as c-myc [2] .
Pathogenic germline APC mutations are mainly caused by frameshift, nonsense mutation, aberrant splicing, missense mutation, and large-fragment deletion within the APC coding sequence [7] , which can lead to genome rearrangement, causing mutated or truncated APC protein. In HGMD (http://www. hgmd.cf.ac.uk/ac) and LOVD (http://www.genomed.org/lovd2/ home.php?select_db=APC), more than 1100 types of APC germline mutations have been identified, covering the whole APC gene. The location and types of the APC germline mutations gene are directly associated with the pathological manifestations and onset age of FAP [8] .
Occurrence of APC mutation types may vary among different patient populations. For example, it was demonstrated that the APC I1307K and E1317Q mutations were not detected in Chinese patients with colorectal cancer [9] . Therefore, it is important to systematically screen the APC mutations among Chinese patients with FAP.
APC mutations have been identified in Chinese pedigrees with FAP. Liu et al. [10] reported 3 novel APC mutations (c.2510C>G, c.2016_2047del, and c.3180_3184del) from 5 Chinese FAP families, which caused truncated APC protein. Zhang et al. [11] identified 2 novel APC pathogenic variants (c.794_795insG/p. Val266SerfsTer11 and c.2142_2143insG/p.His715AlafsTer19) in 5 Chinese families with FAP. We recently identified a spliceacceptor site mutation c.1744-1G>A in intron 14 [12] , singlenucleotide deletion-caused frameshift mutations c.3418delC (p.Pro1140Leufs*25) in exon18 [13] , c.3992_3993insA (p.Thr1332Asnfs*10) in Coding DNA Sequence (CDS)15 [14] , and a large-fragment deletion (exon5-exon16; c.423_8532del) [15] of APC in Chinese FAP pedigrees. However, these reports were mainly based on a small number of pedigrees.
In this study, we enrolled 22 FAP pedigrees to screen the APC gene mutations and observe the correlations of characteristics (e.g., distribution and types) of APC mutations with the clinical manifestations of FAP. Our results will broaden the spectrum of known APC germline mutations and help understand the types and distribution of APC mutations among the Chinese patient population. In addition, this study can be referenced for the determination of early resection for FAP, which might be beneficial to prevention and better treatment for FAPassociated colorectal cancer.
Material and Methods

Patients
Eighty subjects (probands and their family members of 22 FAP pedigrees), registered and diagnosed with FAP between January 2010 and June 2015 at the Registration Center for FAP Pedigrees, Tianjin Union Medical Center (Tianjin, China), were enrolled. This study was approved by the Ethics Committee of the hospital. Written consent was signed by each subject. We collected basic medical information (such as disease history), performed abdominal ultrasound, computed tomography, and colonoscopic examinations, and detected the APC mutations all probands. In each pedigree, after the diagnosis of FAP and detection of APC mutations in the probands, some of their family members were contacted and asked to receive APC mutation screening for health guidance, and the positive subjects (with APC mutations) older than 12 years then underwent colonoscopic examination for presence or absence of FAP. A peripheral blood sample was taken from each subject and DNA was extracted for gene detection.
Diagnosis
The diagnosis of FAP was based on clinical manifestations (e.g., abdominal pain, diarrhoea, hematochezia, abdominal distension, pernicious vomiting, and abdominal mass), abdominal examination (e.g., abdominal swelling, tenderness, existence and size of mass), colonoscopic observation (e.g., existence, number, size, morphology, site of polyps in the colon), abdominal computed tomography observation (e.g., abdominal mass and desmoids), and histopathological examination.
Screening of the APC mutations
The APC mutations were screened by PCR-denaturing high-performance liquid chromatograph (DHPLC) and DNA direct sequencing for micromutations, or by multiplex ligation-dependent probe amplification (MLPA) for large-fragment deletions.
For micromutations, DHPLC was carried out after PCR of the extracted DNA from the blood sample to monitor the PCR product with specific abnormal elution profile (waveform) using the WAVE DHPLC system (Transgenomic, Omaha, NE, USA), with a single injection volume of 5-8 μL, column temperature of 55-62°C, mobile phase of 0.1 mM N-triethyl acetamide and different concentrations of ethyl cyanide, flow velocity of 0.9 ml/min, and detection wavelength of 260 nm. The PCR product with specific abnormal waveform was then sequenced using an Illumina Hiseq2500 analyzer (Illumina, San Diego, CA, USA). DNA sequence with a total length of 98 480 bp, covering 14 colorectal cancer-associated genes (including APC, MLH1, MSH2, MSH6, PMS2, AXIN2, BMPR1A, EPCAM, MLH3, MUTYH, PMS1, PTEN, SMAD4, and STK11), was sequenced, which covered more than 97.84% of APC. The mean sequence depth was over 224 x for each base pair, and the sites with mean sequence depth of over 30 x accounted for 95.32%. Data were analyzed using Illumina Pipeline software (version 1.3.4, Illumina). The sequences were aligned with the human reference genome HG19 assembly. The suspected mutations were amplified by PCR and the products then underwent Sanger sequencing using an ABI PRISM 3730 automated sequencer (Applied Biosystems, Foster, CA, USA), which was analyzed by DNASTAR SeqMan (DNASTAR, Madison, Wisconsin, USA). The detected mutations were searched in the databases (NCBI dbSNP, HapMap, 1000 Genomes Project dataset, and database of 100 Chinese healthy adults).
Large-fragment deletions in the APC was identified by MLPA technique using an MLPA2P043 detection kit (MRC-Holland, Amsterdam, the Netherlands) which contained various probes to recognize the exons and introns of APC. In brief, 100-ng template DNA was denatured at 98°C for 5 min and hybrid captured at 65°C for 24 h. After hybridization, probes were washed and eluted, and the captured DNA was amplified by ligation-mediated polymerase chain reaction (LM-PCR). The PCR reaction system (25 μL) contained 50-100 ng genomic DNA, 0.2 mM dNTP, 0.5 μM upstream primer, 0.5 μM downstream primer, and 2U Tag DNA polymerase. PCR was performed at 95°C for 5 min, 35 cycles of 95°C for 20 s, 55°C for 20 s, 72°C for 20 s, and 72°C for 5 min. PCR products were separated by capillary electrophoresis and detected by ABI StepOne technique using an ABI2100Avant Bioanalyzer sequencer (Applied Biosystems). The copy number of the destined fragments was analyzed with GeneScan 3.1 software (Applied Biosystems).
Results
Between January 2010 and June 2015, probands who were registered and diagnosed at the Registration Center for FAP Pedigrees, Tianjin Union Medical Center, from 22 pedigrees with FAP and totally 80 subjects (including probands and other family members) were enrolled and we detected the APC genotypes.
Among the 22 FAP pedigrees, 5 exhibited mild FAP, 12 had intermediate FAP, and 5 had intensive FAP (Table 1 ). In Pedigrees 7 and 18, the subjects with FAP were assessed with desmoids. Typical images of colonoscopic and histological observation and resected specimens of mild (Pedigree 1#), intermediate (Pedigree 2#), and intensive FAP (Pedigree 18#) are shown ( Figure 1 ). As shown in Table 1 , 19 of 22 FAP pedigrees had the mutations of APC, and 17 types of APC mutations were identified. In Pedigree 1-19, 74 subjects received APC mutation examination, and 31 (41.9%) of them were positive for APC mutations. In Pedigree 20-22, 6 subjects were negative for APC mutations, and 2 subjects in Pedigree 22 were had MUTYH mutations.
All the mutations were heterozygous with autosomal dominant inheritance. APC mutations included frameshift mutations (c.1285delC (in CDS9), c.1350-1352delinsAC (in CDS10) c.2393_2394insT (in CDS15), c.3418delC (in CDS15), c.1238_1239insA (in CDS10), c.3921_3925delAAAAG (in CDS15), c.3992_3993insA (in CDS15), and c.230_233delTAGA (in CDS3)), splice mutations (c.646-1 G>T (in intron 6), c.1744-1G>A (in intron 14) , and c.531+2T>A (in CDS5)), missense mutation (c.289 G>A (in CDS3), and c.474T>G (in CDS4)), nonsense mutation (c.3486T>A (in CDS15), and c.2413C>T (in CDS15)), and large deletional mutations (EX5_16DEL (EX5_16/CDS4_15) and Ex3_16DEl (EX3_16/CDS3_15)). Three mutations were caused by splice, 8 by frameshift, 2 by nonsense mutation, 2 by largefragment deletion, and 2 by missense mutation. Frameshift was the most common mutation means of APC. Two large-fragment deletional mutations were found in 2 cases.
Of the 17 mutations, 2 appeared in introns (intron 6 and 14, respectively), 2 in CDS3, 1 in CDS4, 1 in CDS9, 2 in CDS10, 7 in CDS15, 1 in CDS3_15, and 1 in CDS4_15. CDS15 was the most common mutation site. By searching HGMD and the 1000 Genomes Project dataset, 5 of the identified APC mutations -c.646-1G>T (in Pedigree 1#), c.1285delC (in Pedigree 2#), c.1350-1352delinsAC (in Pedigree 3#), EX3_16/CDS3_15 (in Pedigree 15#), and c.230_233delTAGA (in Pedigree 19#) -have not been previously reported. The sequences of these novel APC mutations are shown in Figure 2 . Table 1 . APC mutations in the pedigrees.
Ped -pedigree; GN -generation number; T/P -total/positive subject number; Het -heterozygosity; AD -autosomal dominant inheritance; FS -frameshift; Suspected -suspected pathogenic mutation; CDS -coding DNA sequence. , and c.3925_3929del AAAAG) frequently occur in Chinese FAP patients, which may thus cause a premature stop codon in APC due to frameshift mutation [16, 17] . In this study, we identified 8 deletion-or insertion-induced frameshift mutations of APC.
In contrast, large-fragment deletional mutations of APC are rare, and only a small portion (about 2%) of mutations are caused by large deletions [2] . For example, Jin et al. identified 2 largefragment deletional mutations (deletion of exons 11 and 10A and that of exon 15 start) of APC in Chinese FAP families [18] . In this study, we identified 2 large-fragment deletional mutations (EX3_16/CDS3_15 and EX5_16/CDS4_15 deletions) in Pedigrees 12 and 15, respectively. In addition, we identified 3 splice-site, 2 nonsense, and 2 missense mutations.
Of the 17 identified mutations in this study, 9 were at CDS15 (including 7 in CDS15, 1 in CDS3_15, and 1 in CDS4_15). This indicates that CDS15 may be the most common mutation site, which is consistent with some previous studies [18, 19] . This Studies have reported APC mutations in Chinese patients with FAP, such as 131564T>C (p.1125Val>Ala) [20] in exon 15 of APC gene, a large deletional mutation c.1936-2148 del [21] in exon 14-15 and intron 14, a frameshift mutation c.1828_1829insG (p.Asp610GlyfsX23) [22] , and c.694C>T [23] . We previously identified mutations c.1744-1G>A in intron 14 [12] , c.3418delC (p.Pro1140Leufs*25) in exon18 [13] , c.3992_3993insA (p.Thr1332Asnfs*10) in CDS15 [14] , and a large-fragment deletion (exon5-exon16; c.423_8532del) [15] of APC gene. However, most of these studies just reported APC mutation from individual or limited pedigrees. In the present study we systematically screened the APC mutations in a relatively large number (22) of Chinese pedigrees with FAP and identified 5 novel mutations not previously reported.
APC mutations occur in over 70% of the Chinese FAP pedigrees, and frameshift mutation is the most common type of APC mutation [24] [25] [26] . For example, Sheng et al. [25] identified 11 mutations (78.6%) from 14 families with FAP, including 9 micromutations and 2 large-fragment deletions. Chiang et al. [24] reported 37 (79%) APC mutations, mainly frameshift mutations, in 47 FAP families. In the present study, we showed a higher rate (86.4%) of APC mutations (19) in 22 Chinese FAP pedigrees compared with the above results. In addition, frameshift mutations accounted for most cases of APC mutations, followed by splice-site mutation and nonsense mutation, which is also consistent with previous reports [24, 25] .
Codon 1309 is a mutational hotspot for APC [8, 16, 17, 26, 27] . For example, a large investigation on 680 FAP patients showed 6.9% (47/680) deletional mutation at codon 1309 [26] . Consistently, in the present study we showed that the reported APC mutations most commonly occurred at codon 1309, since an APC frameshift mutation c.3921_3925delAAAAG (p.Glu1309Aspfs*4) It is important to determine the correlation of APC mutation types and locations with the FAP clinical manifestations. For example, we detected a large-fragment deletion (Ex5-16DEL) in APC in a proband (No. 4 in Generation III) of Pedigree 12, suggesting the other family members to should undergo APC mutation screening. Three of them (No. 1, 5, and 9 in Generation III) had the same mutation as in the proband, but 1 (No. 2 in Generation III) did not have the mutation. Further, these subjects with APC mutations underwent colonoscopic examination and were found to have different extents of polyps; 1 subject was even found to have cancerous polyps. Except for the cancer patient who needed treatment, the other family members with APC mutations were advised to have total prophylactic proctocolectomy for colon cancer before 40 years of age.
A limitation of this study is that although 22 pedigrees were screened, the number of the enrolled subjects from each proband's family was limited. This is related to the fact that in China there is often a lack of necessary knowledge about the progression and prevention of FAP. In the future, education on FAP progression and prevention will be strengthened, and more subjects from each probands' family with FAP will be enrolled to validate these results. In addition, progression of APC mutation-carrying subjects usually occurs at a certain age. Due to a limited observational period, some children with APC mutations were not yet diagnosed with FAP. In the future, these children will be carefully followed to determine if FAP eventually progresses whether preventive surgical resection is carried out, if necessary.
Conclusions
We identified 17 types of mutations of APC gene from 22 pedigrees, including 5 novel mutations not previously reported. This study will broaden the spectrum of known APC pathogenic germline mutations and help understand the types and distribution of APC mutations among Chinese patients with FAP. This study will help determine the corresponding early intervention for FAP among Chinese patients, which could assist prevention and treatment for FAP-associated colorectal cancer.
